Q12866 (MERTK_HUMAN) Homo sapiens (Human)
Tyrosine-protein kinase Mer UniProtKBInterProSTRINGInteractive Modelling
999 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
39 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of the Mer kinase domain in complex with a macrocyclic inhibitor | homo-2-mer | 99.63 | 2×7YS; | |||
| Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in comp… | homo-2-mer | 100.0 | 5×CL; 2×9VS; 1×MG; | |||
| Apo crystal structure of the MerTK kinase domain | monomer | 98.5 | 5×CL; | |||
| Crystal structure of MerTK kinase domain in complex with LDC1267 | monomer | 98.5 | 1×R6H; 3×CL; | |||
| Crystal structure of MerTK kinase domain in complex with UNC2025 | monomer | 98.5 | 1×R6N; 4×CL; 2×DMS; | |||
| Crystal structure of MerTK kinase domain in complex with Merestinib | monomer | 100 | 1×L1X; 3×CL; | |||
| MerTK kinase domain with type 1.5 inhibitor containing a di-methyl pyrazole group | monomer | 98.51 | 1×VJZ; 4×CL; 1×DMS; | |||
| MerTK kinase domain in complex with purine inhibitor | monomer | 98.5 | 1×S4Q; | |||
| Crystal structure of MerTK kinase domain in complex with Gilteritinib | monomer | 98.5 | 1×C6F; 4×CL; 1×DMS; | |||
| MerTK kinase domain with type 1.5 inhibitor containing a tri-methyl pyrazole group | monomer | 98.52 | 1×VK5; 4×CL; | |||
| MerTK kinase domain in complex with a type 2 inhibitor | monomer | 98.49 | 1×S4T; | |||
| MerTK kinase domain with type 1 inhibitor from a DNA-encoded library | monomer | 98.5 | 1×S4Z; | |||
| MerTK kinase domain in complex with a bisaminopyrimidine inhibitor | monomer | 98.49 | 1×S4N; | |||
| MerTK kinase domain with type 1.5 inhibitor from a DNA-encoded library | monomer | 98.5 | 1×S4W; | |||
| MerTK kinase domain with type 1.5 inhibitor containing a di-methyl, cyano pyrazole group | monomer | 98.51 | 1×VK2; 4×CL; 1×DMS; | |||
| Crystal structure of MerTK Kinase domain with BMS794833 | monomer | 98.5 | 1×E0X; 4×CL; 1×DMS; | |||
| Crystal structure of MerTK in complex with a type 1.5 aminopyridine inhibitor | monomer | 100 | 1×R6K; 6×CL; 2×EDO; | |||
| Kinase domain of MERTK in complex with compound 8 | monomer | 100.0 | 2×EDO; | |||
| Crystal structure of catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex … | monomer | 100.0 | 1×OLP; | |||
| Fragment-based Lead Discovery of Indazole-based Compounds as AXL Kinase Inhibitors | monomer | 99.62 | 1×E56; | |||
| Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in comp… | monomer | 100.0 | 3×CL; 1×K0X; | |||
| MerTK kinase domain in complex with quinazoline-based inhbitor | monomer | 100.0 | 1×S4E; 3×SO4; | |||
| Crystal structure of catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex … | monomer | 100.0 | 2×CL; 1×MG; 1×ADP; 1×GOL; | |||
| MerTK kinase domain with type 3 inhibitor from a DNA-encoded library | monomer | 100.0 | 1×S5E; 2×CL; 4×EDO; | |||
| Crystal structure of the MerTK kinase domain with SA4488 | monomer | 100.0 | 1×A1APF; 2×CL; | |||
| Catalytic Domain of the Proto-oncogene Tyrosine-protein Kinase MER | monomer | 100.0 | 1×MG; 1×ANP; 1×BME; | |||
| Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in comp… | monomer | 100.0 | 4×CL; 1×6Q1; | |||
| Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in comp… | monomer | 100.0 | 1×CKJ; 1×CL; 2×CA; | |||
| MerTK kinase domain in complex with NPS-1034 | monomer | 100.0 | 1×S4K; | |||
| Crystal Structure of the MerTK Kinase Domain in Complex with Inhibitor MIPS15692 | monomer | 98.48 | 1×YR7; | |||
| MerTK in complex with small molecule inhibitor 6-{1-[6-(3-hydroxy-3-methylbutoxy)-1,3-benzoxazol-2-… | monomer | 100.0 | 1×A1APH; 4×CL; | |||
| MerTK in complex with small molecule 6-{1-[([1,1'-biphenyl]-4-yl)carbamoyl]azetidin-3-yl}-3-[(1-met… | monomer | 100.0 | 1×A1APG; 2×CL; | |||
| Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in comp… | monomer | 100.0 | 4×CL; 1×MG; 1×MH7; | |||
| Structure-based optimization of 1H-imidazole-2-carboxamides as Axl kinase inhibitors utilizing a Me… | monomer | 99.58 | 1×7AE; | |||
| Structure-based optimization of 1H-imidazole-2-carboxamides as Axl kinase inhibitors utilizing a Me… | monomer | 99.58 | 1×79Y; | |||
| Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in comp… | monomer | 100.0 | 3×CL; 1×4MH; | |||
| Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in comp… | monomer | 100.0 | 5×CL; 1×YDJ; | |||
| Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in comp… | monomer | 100.0 | 4×CL; 1×MG; 1×24K; | |||
| Solution structures of the fn3 domain of human Proto-oncogene tyrosine-protein kinase MER precursor | monomer | 100 | ||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7aaz.1.A | monomer | 0.77 | 1×R6K; | 100.00 | ||